IBM
The vibe: still a fan, just not that much of a fan
BofA took a little air out of IBM’s balloon, lowering its price target to $300 from $340 while leaving the Buy rating untouched. Translation: the bank still thinks IBM can climb, but it’s no longer acting like the stock is headed for the moon with a layover in orbit.
What’s behind the tweak?
The call comes in the middle of earnings-season chatter, with BofA also saying IBM could report roughly in line on Q1 revenue, helped by an early close on part of the Confluent deal. So this isn’t a doom-and-gloom downgrade. It’s more like a reality check after a run-up in expectations.
Why investors should care
Price-target cuts matter because they can influence sentiment, especially for a mega-cap name like IBM that already has plenty of “show me” baggage. Even with the lower target, BofA still sees upside from here — but investors should hear the subtext: the bar may be a little less lofty than before.
Big picture
IBM is still in that tricky zone where the story is part turnaround, part steady compounder, and part “prove it.” A Buy rating helps, but when analysts shave their target, they’re basically saying: nice progress, now don’t get cute.